Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients
Abstract
Nineteen patients with bronchopulmonary infection and myasthenia gravis were enrolled in the study. The microbiological analysis of the specimens of phlegm and bronchial secretion revealed both grampositive and gramnegative bacteria. All the isolates were susceptible to the antibiotic used (cefoperazone/sulbactam). Intravenous immunoglobulins (IvIgs) were used to increase the treatment efficacy, to opsonize the infection foci and to decrease the hospitalization terms. The antibiotic therapy and simultaneous use of intravenous immunoglobulins provided higher clinical efficacy in 16 out of 19 patients (84.2%).
About the Authors
V. I. Sokolova
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
A. G. Sanadze
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
D. A. Sychev
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
M. B. Babarina
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
D. A. Zaykov
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
References
1. Санадзе А.Г. Миастения и миастенические синдромы. 2012; 252.
2. Щербакова Н.И. Патогенетические обоснования стратегии и тактики лечения миастении. Автореферат докторской диссертации). 2007, 3-50.
3. Varelas P.N., Chua H.C., Natterman J. et al. Ventilatory care in myasthenia gravis crisis: assessing the baseline adverse event rate. Crit Care Med 2002 Dec; 30: 12: 2663-2668.
4. Sulkowski S., Sulkowska M. Alveolar cells in cyclophosphamide-induced lung injury. II. Pathogenesis of experimental endogenous lipid pneumonia. Histol Histopathol 1999 Oct; 14 4: 1145-1152.
5. Санадзе А.Г., Соколова В.И., Щербакова Н.И., Никифорук Н.М. Эффективность применения минимальных доз иммуноглобулина в лечении тяжёлой миастении, осложнённой абсцедирующей пневонией. Актуал. вопр. клин. транспор. мед. 2001; 6: 280-286.
6. Skeie G.O. et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. J Neurology 2010; 17: 893-902.
7. Serrano M.C., Rabinstein A.A. Causes and outcomes of acute neuromuscular respiratory failure. Arch Neurol Sep 2010; 67: 9: 1089-1092.
8. Латышева Е.А., Латышева. Т.В. Применение внутривенных иммуноглобулинов в интенсивной терапии. Общая реаниматол. 2012; 8: 3: 45-49.
Review
For citations:
Sokolova V.I., Sanadze A.G., Sychev D.A., Babarina M.B., Zaykov D.A. Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients. Antibiot Khimioter = Antibiotics and Chemotherapy. 2014;59(1-2):20-23. (In Russ.)
Views:
957
Email this article 